StackTerminal.Health

BETA
Research compound

This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.

Hexarelin

Hexarelin is a potent synthetic hexapeptide GHRP known for its strong growth hormone-releasing effects and potential cardioprotective properties through direct cardiac receptor activation.

growth-hormonecardioprotectionrecoverybody-composition
Evidence last reviewed: 19 Apr 2026
Supplement note
Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Sign in to keep a private note on Hexarelin.
Biomarkers studied
Outcomes directly measured across the evidence records below
Hormonal
Growth HormoneCortisol
Evidence
3 records
GH secretion
Patients with alcohol pseudo-Cushing's syndrome and Cushing's diseaseRCT
PUBMEDLow

Hexarelin induced significant ACTH/cortisol responses in patients with Cushing's disease.

Dose: 0 mg
Hormonal changes
Subjects with alcohol pseudo-Cushing's syndrome, Cushing's disease, and normal controlsRCT
PUBMEDLow

Hexarelin induced hormonal changes, including ACTH/cortisol responses, in different subject groups.

Dose: 0 mg
Cardioprotection
General populationCase series
PUBMEDVery low

Hexarelin may provide cardioprotective effects through direct activation of cardiac receptors.

Dose: 0 mgForm: Injection
No direct human studies available; based on theoretical mechanisms.
Forms
Injection
Commonly administered via subcutaneous injection for systemic effects.

Stacks containing Hexarelin

Public community stacks that include this ingredient.

Explore all stacks →
No public stacks include this ingredient yet.